A new study suggests that the antiviral Molnupiravir may “paradoxically” be driving COVID-19 mutations, creating variants of concern. What is going on? It is all about molnupiravir’s mode of action and evolution.
King Charles III's longstanding opposition to genetic engineering is misguided and unconstructive. Genetic modification has long made products better, safer, and cheaper.
